<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04815733</url>
  </required_header>
  <id_info>
    <org_study_id>MoscowCSC</org_study_id>
    <nct_id>NCT04815733</nct_id>
  </id_info>
  <brief_title>Pressure Support Ventilation During Laparoscopic and Abdominal Robotic Surgery.</brief_title>
  <official_title>Pressure Support Ventilation During Laparoscopic and Abdominal Robotic Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Clinical Scientific Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moscow Clinical Scientific Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a single-center, blind, prospective, randomized, controlled trial of pressure&#xD;
      support ventilation (PSVpro) versus pressure control ventilation - volume guaranteed (PCV -&#xD;
      VG) during laparoscopic and robotic abdominal surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study to evaluate the possibility and feasibility of using PSVpro during&#xD;
      anesthesia during long-term laparoscopic and robot-assisted abdominal operations at different&#xD;
      levels of neuromuscular block.&#xD;
&#xD;
      Intervention: We plan to include 100 patients who will undergo elective long (more 2 hours)&#xD;
      laparoscopic or abdominal robotic surgery. All patients will be randomly assigned in two&#xD;
      groups in ratio 1:1. 1 group- deep neuromuscular block and mandatory ventilation; 2 group-&#xD;
      partial neuromuscular block and pressure support ventilation.&#xD;
&#xD;
      Expected Results. PSV may reduce the systemic inflammatory response compared to the mandatory&#xD;
      ventilation during laparoscopic and abdominal robotic surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>t is planned to recruit patients in two groups: group 1-patients who will undergo General anesthesia with deep neuromuscular block and PCV-VG; group 2-patients with partial neuromuscular block and PSVpro.&#xD;
Randomization of patients into two 1:1 groups will be performed by random number generation.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentrations of biomarkers of lung injury</measure>
    <time_frame>1-3 hours after surgery</time_frame>
    <description>Measure concentration of Interleukin-6 (IL-6), Interleukin-8 (IL-8), tumor necrosis factor receptor I / II (sTNF rI / II)) in blood serum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum intraoperative lactate level in the early postoperative period</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>Maximum intraoperative lactate level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The maximum level of vasopressor support during surgery</measure>
    <time_frame>From time of skin incision to time of skin closure assessed up to 24 hours</time_frame>
    <description>Norepinephrine consumption (mcg/kg/h)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of anaesthesia.</measure>
    <time_frame>Period of time from induction to volatile anesthetic supply stop assessed up to 24 hours</time_frame>
    <description>Duration of anaesthesia.</description>
  </other_outcome>
  <other_outcome>
    <measure>Procedure time</measure>
    <time_frame>Period of time from intubation to extubation assessed up to 24 hours</time_frame>
    <description>Length of ventilation</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of stay (LOS) in the intensive care unit (ICU).</measure>
    <time_frame>Period of time from ICU arrival to discharge from ICU assessed up to 1 year</time_frame>
    <description>Length of stay (LOS) in the intensive care unit (ICU).</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to reach an Aldrete score &gt; 9 points after anaesthesia</measure>
    <time_frame>Period of time from volatile anesthetic suplly stop to time when patient has more than 9 points according Aldrete score assessed up to 24 hours</time_frame>
    <description>Time to reach an Aldrete score &gt; 9 points after anaesthesia</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative consumption of muscle relaxant</measure>
    <time_frame>Since skin incision to skin closure assessed up to 24 hours</time_frame>
    <description>mg/kg of muscle relaxant</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative consumption of reversal agents.</measure>
    <time_frame>Since skin incision to skin closure assessed up to 24 hours</time_frame>
    <description>mg/kg of reversal agents.</description>
  </other_outcome>
  <other_outcome>
    <measure>Supplemental oxygen in the early postoperative period</measure>
    <time_frame>Since extubation up to 24 hours after extubation</time_frame>
    <description>Duration of oxygen supply</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of recovery score-40</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The QoR-40 incorporates five dimensions of health: patient support, comfort, emotions, physical independence, and pain; each item is graded on a five-point Likert scale.&#xD;
QoR-40 scores range from 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery).</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter FVC after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>FVC before surgery (L) - FVC after surgery (L)</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter FEV1 after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>FEV1 before surgery (L)- FEV1 after surgery (L)</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter FEV1/FVC after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>FEV1/FVC before surgery (percentage %) - FEV1/FVC after surgery (percentage %)</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter PEF after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>PEF before surgery (L/s) - PEF after surgery (L/s)</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter VC after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>VC before surgery (L) - VC after surgery (L)</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes of spirometry parameter FEV1/VC after surgery</measure>
    <time_frame>1 hour and 24 hours after surgery</time_frame>
    <description>FEV1/VC before surgery (percentage %) - FEV1/VC after surgery (percentage %)</description>
  </other_outcome>
  <other_outcome>
    <measure>Volume of atelectasis of lungs after surgery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Volume of the lungs measure according to CT lung The volume of atelectasis is the difference in volumes of lungs before and after surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>The level of pain assess after surgery by Numeric Rating Scale (NRS)</measure>
    <time_frame>1 hour after surgery</time_frame>
    <description>No pain - 0, worst pain - 10</description>
  </other_outcome>
  <other_outcome>
    <measure>The level of pain assess after surgery by Numeric Rating Scale (NRS)</measure>
    <time_frame>3 hours after surgery</time_frame>
    <description>No pain - 0, worst pain - 10</description>
  </other_outcome>
  <other_outcome>
    <measure>The level of pain assess after surgery by Numeric Rating Scale (NRS)</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>No pain - 0, worst pain - 10</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of stay (LOS) in hospital</measure>
    <time_frame>28 days</time_frame>
    <description>Length of stay (LOS) in hospital</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ventilator-Induced Lung Injury</condition>
  <arm_group>
    <arm_group_label>Mandatory ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>deep neuromuscular block and mandatory ventilation (PCV-VG);</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure support ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>partial neuromuscular block and pressure support ventilation (PSVpro).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mandatory ventilation</intervention_name>
    <description>Use PCV-VG</description>
    <arm_group_label>Mandatory ventilation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pressure support ventilation</intervention_name>
    <description>Use PSVpro</description>
    <arm_group_label>Pressure support ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Written consent.&#xD;
&#xD;
          -  Men and women aged 18 years or more.&#xD;
&#xD;
          -  The physical status from ASA classification I, II or III.&#xD;
&#xD;
          -  BMI &lt;= 34.9 kg / m2.&#xD;
&#xD;
          -  Low risk of respiratory complications.&#xD;
&#xD;
          -  Laparoscopic surgery in the pelvis.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  The physical status from ASA IV or V.&#xD;
&#xD;
          -  BMI&gt; = 35 kg / m2.&#xD;
&#xD;
          -  Neuromuscular disease.&#xD;
&#xD;
          -  Allergy to Anesthetic Agents.&#xD;
&#xD;
          -  Operations on two cavities.&#xD;
&#xD;
          -  Operations on the chest cavity.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valerii Subbotin, PhD</last_name>
    <phone>+7-495-304-30-39</phone>
    <email>v.subbotin@mknc.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moscow Clinical Scientific Center</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrei Klimov, MD</last_name>
      <phone>+79152119373</phone>
      <email>an.an.klimov@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2021</study_first_posted>
  <last_update_submitted>March 22, 2021</last_update_submitted>
  <last_update_submitted_qc>March 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moscow Clinical Scientific Center</investigator_affiliation>
    <investigator_full_name>Valerii Subbotin</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>pressure support ventilation</keyword>
  <keyword>anaesthesia</keyword>
  <keyword>lung injury</keyword>
  <keyword>laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Ventilator-Induced Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

